Message from the CEO

Our stance on CBD is very clear, we align ourselves with the FDA – particularly in the following statement:

“Cannabis and cannabis-derived products claiming in their marketing and promotional materials that they’re intended for use in the diagnosis, cure, mitigation, treatment, or prevention of diseases (such as cancer, Alzheimer’s disease, psychiatric disorders and diabetes) are considered new drugs or new animal drugs and must go through the FDA drug approval process for human or animal use before they are marketed in the U.S. Selling unapproved products with unsubstantiated therapeutic claims is not only a violation of the law, but also can put patients at risk, as these products have not been proven to be safe or effective. This deceptive marketing of unproven treatments raises significant public health concerns, as it may keep some patients from accessing appropriate, recognized therapies to treat serious and even fatal diseases.”

 
Fusia Foods and Sapphire Vine, shall not make any such claims. We acknowledge hemp, and its derivatives, as “Generally Recognized As Safe.” Sapphire Vine has every incoming batch of CBD used in our products tested by a third party lab to have:
 

    1. No Pesticides
    2. No heavy metals
    3. Below .03 THC by dry weight
    4. 1120/c2 CBD
    5. US sourced CBD

 
These are the 5 minimum requirements for any CBD that we purchase.

Our commitment to our clients: Every batch of product made by our facility shall be sent out for testing by a third-party WELL RECOGNIZED and ACCEPTED laboratory and tested for the following:

1. Pesticides
2. Heavy Metals
3. Below .03 THC
4. Proper CBD amount as claimed on our product.

A COA shall be issued by the lab and available through online examination by any interested party.

It is our intent to be the most responsible and recognized company in that space.

Marwan Moheyeldien

CEO